50,000,000 COMMON STOCK SALES AGREEMENTSales Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
Revance Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
SECOND AMENDMENT TO LOAN AND LEASE AGREEMENTLoan and Lease Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations
This Second Amendment (the “Second Amendment”) to Loan and Lease Agreement is entered into as of February 26, 2015 (the “Second Amendment Effective Date”) by and between ESSEX CAPITAL CORPORATION (“Essex”) and REVANCE THERAPEUTICS, INC. (“Company”).
REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCKWarrant Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
THIS CERTIFIES THAT, for value received, ESSEX CAPITAL CORPORATION, with its principal office at 1486 East Valley Road, 2nd Floor, Santa Barbara, California 93108, or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Revance Therapeutics, Inc., a Delaware corporation (the “Company”), with its principal office at 7555 Gateway Boulevard, Newark, California 94560, the Exercise Shares (defined below). This Warrant is being issued in connection with that certain Loan and Lease Agreement dated as of December 20, 2013, as amended by the First Amendment to Loan and Lease Agreement dated the date hereof (the "Effective Date") between Holder and Company (as so amended, the "Agreement").
